Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank check special purpose acquisition company formed to pursue a business combination in the healthcare technology sector. The company filed its annual report on Form 10-K with the Securities and Exchange Commission on May 4, 2026, under accession number 0001493152-26-021108, covering its most recently completed fiscal year. AFJK went public targeting opportunities across health technology and related life sciences industries, with its search mandate reflecting growing investor interest in technology-driven healthcare businesses. As of its most recent annual filing, the company continues its search for a qualifying acquisition target. Sign up for SpacDesk to access full sponsor details, deal timelines, filing history, and analytics on AFJK and the entire SPAC market.